Adherium Limited has appointed Jane Lapon as Head of Global Market Access & Reimbursement. This appointment further strengthens Adherium's capability to successfully commercialise existing products and to drive future growth by ensuring the portfolio delivers value to payers, physicians and patients. In this newly created role, Ms. Lapon will lead all aspects of Market Access and Reimbursement for the Company with responsibility for developing and executing strategies to obtain reimbursement for the Hailie® platform in all targeted markets, optimise funding streams where they currently exist and ensure current and future portfolio offerings are developed optimally from a payer perspective. She will report to Mike Motion, Chief Commercial Officer, and will join Adherium's senior management team. Most recently, Ms. Lapon held the position of VP Global Market Access for Boston Scientific.